Do drug transporter (ABCB1) SNPs and P-glycoprotein function influence cyclosporine and macrolides exposure in renal transplant patients? Results of the pharmacogenomic substudy within the symphony study.
about
Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance)Developments in renal pharmacogenomics and applications in chronic kidney diseasePersonalization of the immunosuppressive treatment in renal transplant recipients: the great challenge in "omics" medicineCCL21 Facilitates Chemoresistance and Cancer Stem Cell-Like Properties of Colorectal Cancer Cells through AKT/GSK-3β/Snail Signals.Influence of cyclosporine and everolimus on the main mycophenolate mofetil pharmacokinetic parameters: Cross-sectional study.The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation.Pharmacogenetics and immunosuppressive drugs in solid organ transplantation.Pharmacogenetics and immunosuppressive drugs.Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients.Role of vitamin D pathway gene polymorphisms on rifampicin plasma and intracellular pharmacokinetics.Pomelo enhances cyclosporine bioavailability in healthy male Thai volunteers.Post-transplant recurrent pericarditis with pericardial tamponade is successfully treated with colchicine: A case report.Indoxyl Sulfate Upregulates Liver P-Glycoprotein Expression and Activity through Aryl Hydrocarbon Receptor Signaling.
P2860
Q24289538-61E69F38-1293-4521-9F6B-F55083C1A03FQ26999279-CD209B33-0C74-4A20-A057-7947A8718A32Q28082746-590012D1-AAA0-4FD6-B584-B13AFD94EB17Q36448376-195B295C-FD32-46A6-916F-A60D392270A7Q37737279-DC36DACD-A1D9-4B7C-8774-F748C8F518C3Q38163945-11874619-005C-433F-89DD-D0C90E92D44FQ38253383-5A787884-E1F2-4901-9053-05F3D9C2D127Q38258677-B0AB1626-BE1A-473B-A216-BD6C9746C198Q38668601-07ABFB3B-2387-4ADC-B09F-A3E1BF6EF9E5Q40180361-3D9A973A-8FC5-4F11-8600-53AAE7D937CAQ42693981-CF14FD9E-1675-48FF-9B67-48866605C622Q42752999-14342F6A-8146-4A89-B77F-FFF51DD94556Q48150663-AA0EF81E-8FB9-4B77-8B93-077510C9B4B1
P2860
Do drug transporter (ABCB1) SNPs and P-glycoprotein function influence cyclosporine and macrolides exposure in renal transplant patients? Results of the pharmacogenomic substudy within the symphony study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Do drug transporter (ABCB1) SN ...... udy within the symphony study.
@en
Do drug transporter
@nl
type
label
Do drug transporter (ABCB1) SN ...... udy within the symphony study.
@en
Do drug transporter
@nl
prefLabel
Do drug transporter (ABCB1) SN ...... udy within the symphony study.
@en
Do drug transporter
@nl
P2093
P2860
P356
P1476
Do drug transporter (ABCB1) SN ...... udy within the symphony study.
@en
P2093
Anna Caldés
Federico Oppenheimer
Helena Colom
Henrik Ekberg
Inés Llaudó
Jaime Sánchez-Plumed
Joan Torras
Josep M Cruzado
Josep M Grinyó
Maria Sarrias
P2860
P304
P356
10.1111/TRI.12018
P577
2012-12-07T00:00:00Z